DECLEVE
Mandates through the years
4 namesAnne-Catherine BAUS
Managing director
Managing director
Annie DECLEVE
Director
Director
Michel DESTREBECQ
Managing director
Managing director
PHARMA HOLD
Managing director
Managing director
Earliermandate already running before its first mention
Mandates as a list
- Anne-Catherine BAUS
- Managing director, until 27-12-2019
- Annie DECLEVE
- Director, appointed by deed of 26-06-2017, until 27-12-2019
- Michel DESTREBECQ
- Managing director, until 27-12-2019
- PHARMA HOLD
- Managing director, until 27-12-2019
Control
Consolidating parent
Equity €142,224
Loss €223 in 2025 (loss €6,895 in 2024)
Checked score 92
Source: parent in own accounts 2017
consolidates
This company
DECLEVE
Equity €20,515
Loss €21,188 in 2018
Capital
- Capital
- €75,000
- Source
- 2018 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- PHARMA HOLD
Source: parent in its own accounts, lists of holdings in the owners' accounts